Asian American Pacific Islander Researchers and Scholars Workgroup (AAPI)
About NIDA
- 2010 Strategic Plan
- Organization
- Offices
- Office of the NIDA Director (OD)
- Director's Page
- AIDS Research Program (ARP)
- International Program (IP)
- Intramural Research Program (IRP)
- Special Populations Office (SPO)
- Related Funding Opportunities
- NIDA SPO Research Programs
- Research Training Opportunities
- African American Researchers and Scholars Work Group (AARSWG)
- Asian American Pacific Islander Researchers and Scholars Workgroup (AAPI)
- National Hispanic Science Network
- American Indian/Alaska Native Researchers and Scholars Workgroup (AIANRSWG)
- American Indian/Alaska Native (AI/AN) Coordinating Committee
- Staff Listing
- LPC Staff
- SPO/Lead Program Coordinating (LPC) Task Force
- FAQs About: Research Supplements to Promote Diversity in Health-Related Research (Diversity Supplements)
- Instructions to Principal Investigators Applying for Research Supplements to Promote Diversity in Health-Related Research
- NIDA Consortium on Diversity Affairs
- Health Disparities
- Women & Sex/Gender Differences Research Program
- Office of Management (OM)
- Office of Extramural Affairs (OEA)
- Office of Science Policy and Communications (OSPC)
- Office of the NIDA Director (OD)
- CCTN
- Divisions
- Workgroups, Interest Groups and Consortia
- Offices
- Director's Page
- Legislative Activities
- Advisory Boards & Groups
- Employment Opportunities
- Donating to NIDA
- Contact Us
- Other Resources
Mission and Goals
The AAPI Working Group fosters interdisciplinary and translational research focusing on the drug use and abuse and related health conditions affecting AAPIs. It is also committed to increasing the participation and development of AAPI scientists in the fields of drug use, abuse and related research, and to increasing collaborative activities among research scientists and AAPI communities.
Major Highlights and Accomplishments
The AAPI Workgroup has identified and engaged a large group of NIH researchers representing a multitude of disciplines interested in interdisciplinary and translational research as it affects AAPI communities.
The Workgroup members are working with its core of researchers in order to grow and expand the membership, mentoring, and scientific capacity.
-
NIDA Asian American/Pacific Islander Researchers & Scholars Workgroup Meeting
“Advancing AAPI Drug Abuse/Mental Health Prevention Sciences and Treatment: Transdisciplinary Frameworks” June 2-3, 2010, Alexandria VA
This meeting focused on mentor training and development and was available to AAPI researchers interested in mentorship or a career in substance abuse research focused on AAPI-relevant issues. 26 mentees attended.
-
Diversity Alumni Meeting, Joint Meeting of NIDA’s Racial/Ethnic Minority Workgroups & NIDA AAPI Workgroup Meeting
November 7-8, 2011, Bethesda, MD
-
AAPI Early Career Investigator Symposium, affiliated with NIDA Mini-convention, held on November 11, 2011, Washington DC
The AAPI Workgroup sponsored 6 travel awards for emerging scientists from different minority groups who attended and presented their research at the symposium. The program accentuated the workgroup’s mission in coaching and training of socially and economically disadvantaged minority junior investigators. It permitted the junior investigators to interact with AAPI investigators. The AAPI Mentoring and Training session consisted of topics on scientific writing, benefit of serving NIH study sections and an orientation for junior investigators to attend NIDA Grant Workshop.
- The AAPI Workgroup provided travel awards for emerging scientists to attend and participate at the 2012 Society on Neuroimmune Pharmacology (SNIP) conference, April 25-28 in Honolulu, Hawaii. SNIP is one of the scientific forums to nurture the early careers of this special population of young investigators.
Upcoming Events
-
2012 College on Problems of Drug Dependence (CPDD) Meeting, June 9-14 in Palm Springs, CA
The AAPI Workgroup is providing 9 travel awards for emerging scientists to attend and present posters at the 2012 CPDD international conference. On behalf of NIDA Special Population Office, it will conduct an on-site training/mentoring program in this conference for NIDA racial ethnic minority early stage investigators. It has also collaborated with NIDA’s International Office in sponsoring international scientists.
-
2012 Health Disparity Conference, July 11-13 in Fort Worth, Texas
The AAPI Workgroup sponsors a workshop in this conference entitled “Tobacco Smoking, HIV/AIDS and Cancer in Health Disparity Population”. It will introduce NIDA and NIDA’s science to the audience and the community and will present program priorities, research opportunities at NIDA and NIH.
Resources and Links
- http://napafasa.org/
- U.S. DHHS Office on Women’s Health – Asian-Americans
- National Library of Medicine Asian American Health – Substance Abuse
- CDC Fact Stats – Asian or Pacific Islander Population
Workgroup Roster
-
Ana Anders, LICSW
Senior Advisor, Special Populations Office
National Institute on Drug Abuse/NIH
6001 Executive Boulevard, Room 4216, MSC 9567
Bethesda, MD 20892-9567
(301) 435-0919
(301) 480-8179 -
Shilpa Buch, PhD
Professor and Vice Chair for Research
Dept of Pharmacology & Experimental Neuroscience
University of Nebraska Medical Center
985880 Nebraska Medical Center, DRC 8011
Omaha, NE 68198-5880
(402) 559-3165
(402) 559-3744 -
Linda Chang, MD
Professor, Department of Medicine
University of Hawaii, John A. Burns School of Medicine
The Queen's Medical Center
Honolulu, HI 96813
(808) 586-7467
(808) 586-7486 -
Sulie L. Chang, PhD
Professor, Seton Hall University
Director, Institute of NeuroImmune Pharmacology
400 South Orange Avenue
South Orange, NJ 07079
(973) 761-9456
(973) 275-2489 -
Johnny J. He, PhD
Associate Dean, Biomedical Education and Research;
Professor, Cell Biology and Anatomy
University of North Texas Health Science Center
EAD-832B
3500 Camp Bowie Boulevard
Fort Worth, TX 76107
(817) 735-2642
(817) 738-0181 -
Yih-Ing Hser, PhD
Professor and Center Director
UCLA Center of Advancing Longitudinal Drug Abuse Research
1640 South Sepulveda Boulevard, Suite 200
Los Angeles, CA 90025
(310) 267-5388 -
Anil Kumar, PhD
Chair and Professor, School of Pharmacy
University of Missouri-Kansas City, Division of Pharmacology
2411 Holmes, M3-111
Kansas City, MO 64108
(816) 235-2415
(816) 235-1776 -
Ming D. Li, PhD
Professor, Psychiatry and Neurobehavioral Sciences
University of Virginia School of Medicine
1670 Discovery Drive, Suite 110
Charlottesville, VA 22911
(434) 243-0566
(434) 973-7031 -
Yu “Woody” Lin, Ph.D.
Program Director,
Clinical Neuroscience Branch
Division of Clinical Neuroscience and Behavioral Research
National Institute on Drug Abuse
6001 Executive Boulevard
Bethesda, MD 20892-9555
(301) 435-1318 -
Walter Ling, MD
Professor of Psychiatry
UCLA Integrated Substance Abuse Programs
Director of Integrated Substance Abuse Programs
11075 Santa Monica Boulevard, Suite 200
Los Angeles,CA 90025
(310) 267-5888
(310) 312-0552 -
Rumi Kato Price, PhD
Professor, Washington University School of Medicine
Medical Box 8134
660 South Euclid Avenue
St Louis, MO 63110
(314) 286-2282
(314) 286-2285 -
Joseph T. Sakai, MD
Assistant Professor, Division of Substance Dependence
University of Colorado Denver, School of Medicine
12469 East 17th Place, Building 400
Aurora, CO 80045
(303) 724-3182
(303) 724-3178 -
Betty Tai, PhD
Director, Center for the Clinical Trials Network
National Institute on Drug Abuse/NIH
6001 Executive Boulevard, Room 3120
Bethesda, MD 20892-9557
(301) 443-6697
(301) 443-2317 -
Madhukar H. Trivedi, MD
Professor of Psychiatry, University of Texas Southwestern Medical Center
Director, Mood Disorders Research Program and Clinic
5323 Harry Hines Boulevard
Dallas, TX 75390
(214) 648-0181 -
Gene-Jack Wang, MD
Senior Scientist
Brookhaven National Laboratory, Medical Department
Building 490, PO Box 5000
Upton, NY 11973-5000
(631) 344-3608 -
Li-Tzy Wu, ScD
Professor, Psychiatry and Behavioral Sciences
Duke University Medical Center
DUMC Box 3419
Durham, NC 27710
(919) 889-9369
(919) 677-8480 -
Bryan K. Yamamoto, PhD
Professor and Chairman
University of Toledo College of Medicine, Department of Neurosciences
Mail Stop #1007, 3000 Arlington Avenue
Toledo, OH 43614-2598
(419) 383-6115
(419) 383-3008
This page was last updated April 20, 2012.
Featured Publication
Drugs, Brains, and Behavior - The Science of Addiction
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.